A World Malaria Map: Plasmodium falciparum Endemicity in 2007, PLoS Medicine, vol.118, issue.3, p.1000048, 2007. ,
DOI : 10.1371/journal.pmed.1000048.sd009
Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan Africa, Tropical Medicine and International Health, vol.13, issue.1, pp.488-506, 2003. ,
DOI : 10.1086/315034
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials, The Lancet, vol.374, issue.9700, pp.1533-1542, 2009. ,
DOI : 10.1016/S0140-6736(09)61258-7
Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum, Molecular and Biochemical Parasitology, vol.69, issue.1, pp.135-138, 1995. ,
DOI : 10.1016/0166-6851(94)00207-4
Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum., Proceedings of the National Academy of Sciences, vol.85, issue.23, pp.9109-9113, 1988. ,
DOI : 10.1073/pnas.85.23.9109
Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain, Antimicrob Agents Chemother, vol.42, pp.164-169, 1998. ,
Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria., Proceedings of the National Academy of Sciences, vol.85, issue.23, pp.9114-9118, 1988. ,
DOI : 10.1073/pnas.85.23.9114
The evolution of drug-resistant malaria, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.103, issue.1, pp.11-14, 2009. ,
DOI : 10.1016/j.trstmh.2008.11.002
Characterisation of the dihydrofolate reductase-thymidylate synthetase gene from human malaria parasites highly resistant to pyrimethamine, Gene, vol.76, issue.1, pp.41-52, 1989. ,
DOI : 10.1016/0378-1119(89)90006-1
Mechanisms of Resistance of Malaria Parasites to Antifolates, Pharmacological Reviews, vol.57, issue.1, pp.117-145, 2005. ,
DOI : 10.1124/pr.57.1.4
In Vitro Activity of Antifolate and Polymorphism in Dihydrofolate Reductase of Plasmodium falciparum Isolates from the Kenyan Coast: Emergence of Parasites with Ile-164-Leu Mutation, Antimicrobial Agents and Chemotherapy, vol.53, issue.9, pp.3793-3798, 2009. ,
DOI : 10.1128/AAC.00308-09
P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates, Drug Resistance Updates, vol.1, issue.6, pp.389-396, 1998. ,
DOI : 10.1016/S1368-7646(98)80014-9
Populations from Southwest Uganda, The Journal of Infectious Diseases, vol.197, issue.11, pp.1598-1604, 2008. ,
DOI : 10.1086/587845
Plasmodium falciparum Drug Resistance in Madagascar: Facing the Spread of Unusual pfdhfr and pfmdr-1 Haplotypes and the Decrease of Dihydroartemisinin Susceptibility, Antimicrobial Agents and Chemotherapy, vol.53, issue.11, pp.4588-4597, 2009. ,
DOI : 10.1128/AAC.00610-09
URL : https://hal.archives-ouvertes.fr/pasteur-00741124
from Sites across Africa, The Journal of Infectious Diseases, vol.196, issue.1, pp.165-172, 2007. ,
DOI : 10.1086/518512
, Madagascar, Emerging Infectious Diseases, vol.14, issue.7, pp.1166-1167, 2008. ,
DOI : 10.3201/eid1407.071498
Stepwise acquisition of pyrimethamine resistance in the malaria parasite, Proceedings of the National Academy of Sciences, vol.106, issue.29, pp.12025-12030, 2009. ,
DOI : 10.1073/pnas.0905922106
Assessment of the efficacy of antimalarial drugs recommended by the National Malaria Control Programme in Madagascar: Up-dated baseline data from randomized and multi-site clinical trials, Malaria Journal, vol.7, issue.1, p.55, 2008. ,
DOI : 10.1186/1475-2875-7-55
Accuracy and reliability of malaria diagnostic techniques for guiding febrile outpatient treatment in malaria-endemic countries, Am J Trop Med Hyg, vol.78, pp.217-221, 2008. ,
Simultaneous identification of the four human Plasmodium species and quantification of Plasmodium DNA load in human blood by real-time polymerase chain reaction, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.97, issue.4, pp.387-390, 2003. ,
DOI : 10.1016/S0035-9203(03)90065-4
Origins of the Recent Emergence of Plasmodium falciparum Pyrimethamine Resistance Alleles in Madagascar, Antimicrobial Agents and Chemotherapy, vol.54, issue.6, pp.2323-2329 ,
DOI : 10.1128/AAC.01511-09
URL : https://hal.archives-ouvertes.fr/pasteur-00835565
Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique., Antimicrobial Agents and Chemotherapy, vol.16, issue.6, pp.710-718, 1979. ,
DOI : 10.1128/AAC.16.6.710
Highly pyrimethamine-resistant alleles of dihydrofolate reductase in isolates of Plasmodium falciparum from Tanzania, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.96, issue.6, pp.674-676, 2002. ,
DOI : 10.1016/S0035-9203(02)90349-4
In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of Plasmodium falciparum, Am J Trop Med Hyg, vol.50, pp.193-199, 1994. ,
In vitro susceptibility to pyrimethamine of DHFR I164L single mutant Plasmodium falciparum, Malaria Journal, vol.10, issue.1, p.283, 2011. ,
DOI : 10.1016/S0035-9203(02)90349-4
URL : https://hal.archives-ouvertes.fr/pasteur-00631585